Pharmacogenetic Impact of CYP2C19 Variants on Diazepam Treatment Outcomes in Alcohol Withdrawal Syndrome

Özkan-Kotiloğlu, S., Tok, K. C., Danışman, M., Yıldırım, M. A., Bozmaoğlu, C. H., Gumustas, M., Özgür-İlhan, İ., Doğan, Ö., Süzen, H. S., & Kaya-Akyüzlü, D. (2026). Pharmacogenetic Impact of CYP2C19 Variants on Diazepam Treatment Outcomes in Alcohol Withdrawal Syndrome. Molecular Neurobiology, 63(1), 976. https://doi.org/10.1007/s12035-026-06282-0

Özkan-Kotiloğlu S, Tok KC, Danışman M, Yıldırım MA, Bozmaoğlu CH, Gumustas M, et al. Pharmacogenetic Impact of CYP2C19 Variants on Diazepam Treatment Outcomes in Alcohol Withdrawal Syndrome. Molecular Neurobiology. 2026;63(1):976. doi:10.1007/s12035-026-06282-0

Özkan-Kotiloğlu, Selin, Kenan Can Tok, Mustafa Danışman, Mukaddes Asena Yıldırım, Ceren H. Bozmaoğlu, Mehmet Gumustas, İnci Özgür-İlhan, Özlem Doğan, H. Sinan Süzen, and Dilek Kaya-Akyüzlü. 2026. “Pharmacogenetic Impact of CYP2C19 Variants on Diazepam Treatment Outcomes in Alcohol Withdrawal Syndrome.” Molecular Neurobiology 63 (1): 976. https://doi.org/10.1007/s12035-026-06282-0.

Özkan-Kotiloğlu, Selin, et al. “Pharmacogenetic Impact of CYP2C19 Variants on Diazepam Treatment Outcomes in Alcohol Withdrawal Syndrome.” Molecular Neurobiology, vol. 63, no. 1, 2026, p. 976. https://doi.org/10.1007/s12035-026-06282-0.

Özkan-Kotiloğlu, S., Tok, K.C., Danışman, M., Yıldırım, M.A., Bozmaoğlu, C.H., Gumustas, M., Özgür-İlhan, İ., Doğan, Ö., Süzen, H.S. and Kaya-Akyüzlü, D. (2026) ‘Pharmacogenetic Impact of CYP2C19 Variants on Diazepam Treatment Outcomes in Alcohol Withdrawal Syndrome’, Molecular Neurobiology, 63(1), p. 976. doi:10.1007/s12035-026-06282-0.